SynOV1.1 Intratumoral Injection Study
NCT04612504
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
15
Enrollment
INDUSTRY
Sponsor class
Conditions
Hepatocellular Carcinoma
Interventions
BIOLOGICAL:
SynOV1.1
Sponsor
Beijing Syngentech Co., Ltd.